Anaerobe bakterier og resistens. Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark

Similar documents
Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

on February 12, 2018 by guest

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

What s new in EUCAST methods?

Case Report Multidrug-Resistant Bacteroides fragilis Bacteremia in a US Resident: An Emerging Challenge

EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)

European Committee on Antimicrobial Susceptibility Testing

Should we test Clostridium difficile for antimicrobial resistance? by author

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

ESCMID Online Lecture Library. by author

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS

European Committee on Antimicrobial Susceptibility Testing

EUCAST recommended strains for internal quality control

PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Quality assurance of antimicrobial susceptibility testing

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria

Antimicrobial Susceptibility of Clinically Relevant Gram-Positive Anaerobic Cocci Collected over a Three-Year Period in the Netherlands

Monitoring of antimicrobial resistance in Campylobacter EURL AR activities in framework of the new EU regulation Lina Cavaco

56 Clinical and Laboratory Standards Institute. All rights reserved.

Mechanism of antibiotic resistance

Antimicrobial Resistance in Human Oral and Intestinal Anaerobic Microfloras

SESSION XVI NEW ANTIBIOTICS

Practical approach to Antimicrobial susceptibility testing (AST) and quality control

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

January 2014 Vol. 34 No. 1

Antimicrobial Resistance and Prescribing

Antimicrobial Susceptibility of Clinical Isolates of Bacteroides fragilis Group Organisms Recovered from 2009 to 2012 in a Korean Hospital

Service Delivery and Safety Department World Health Organization, Headquarters

Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing

Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems

Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Detecting / Reporting Resistance in Nonfastidious GNR Part #2. Janet A. Hindler, MCLS MT(ASCP)

Introduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail.

The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards

WHY IS THIS IMPORTANT?

ENTEROCOCCI. April Abbott Deaconess Health System Evansville, IN

Prevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India

Principles and Practice of Antimicrobial Susceptibility Testing. Microbiology Technical Workshop 25 th September 2013

What is new in 2011: Methods and breakpoints in relation to subcommittees and expert groups. by author. Gunnar Kahlmeter, Derek Brown

Antimicrobials & Resistance

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Global Alliance for Infections in Surgery. Better understanding of the mechanisms of antibiotic resistance

Methicillin-Resistant Staphylococcus aureus

EUCAST-and CLSI potency NEO-SENSITABS

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

UNDERSTANDING YOUR DATA: THE ANTIBIOGRAM

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

Antimicrobial Resistance and Molecular Epidemiology of Staphylococcus aureus in Ghana

Acinetobacter Resistance in Turkish Tertiary Care Hospitals. Zeliha KOCAK TUFAN, MD, Assoc. Prof.

Multi-drug resistant microorganisms

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update

Int.J.Curr.Microbiol.App.Sci (2018) 7(8):

Antimicrobial Resistance Strains

Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory

EUCAST Workshop: Antimicrobial susceptibility testing with EUCAST breakpoints and methods

Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017

Why we perform susceptibility testing

Sheffield User Group Day October Members of the BSAC Working party on Susceptibility Testing present:

Introduction to Pharmacokinetics and Pharmacodynamics

DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA

Multicenter Study of In Vitro Susceptibility of the Bacteroides fragilis Group, 1995 to 1996, with Comparison of Resistance Trends from 1990 to 1996

Mili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

There are two international organisations that set up guidelines and interpretive breakpoints for bacteriology and susceptibility

ETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens

2015 Antimicrobial Susceptibility Report

Antibiotics & Resistance

Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece

EARS Net Report, Quarter

ESCMID Online Lecture Library. by author

ESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL

SAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals

STAPHYLOCOCCI: KEY AST CHALLENGES

IMPORTANCE OF GLOBAL HARMONIZATION OF ANTIMICROBIAL SUSCEPTIBILITY TESTING IN CANADA FOR DEFINING ANTIMICROBIAL RESISTANCE

Antibiotic resistance and what can be done

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

Dr Vivien CHUANG Associate Consultant Infection Control Branch, Centre for Health Protection/ Infectious Disease Control and Training Center,

Antibiotic resistance a mechanistic overview Neil Woodford

Christiane Gaudreau* and Huguette Gilbert

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

EDUCATIONAL COMMENTARY CURRENT METHODS IN ANTIMICROBIAL SUSCEPTIBILITY TESTING

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

Microbiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:

CONTAGIOUS COMMENTS Department of Epidemiology

MRSA surveillance 2014: Poultry

APPENDIX III - DOUBLE DISK TEST FOR ESBL

Epidemiology and Antimicrobial Susceptibility of Anaerobic Bloodstream Infections: A 10 Years Study

International Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT

Antibacterial susceptibility testing

Transcription:

Anaerobe bakterier og resistens Ulrik Stenz Justesen Klinisk Mikrobiologisk Afdeling Odense Universitetshospital Odense, Denmark

Programme anaerobic bacteria Carbapenem and metronidazole resistance New methods for detecting resistance, including MALDI-TOF (and WGS) supplemented with a few cases 2 the first mentometerfråga

The Danish situation 3 13-05-2015

Carbapenem-resistance The most common type of carbapenem-resistance in anaerobes is metallo-betalactamase production in Bacteroides fragilis Metallo-betalactamases hydrolyses (break down) almost all betalactam antibiotics penicillins, cefalosporins and carbapenems 4

Carbapenem-resistance and the cfia gene cfia gene (chromosomal) encodes a metallo-betalactamase (MBL) in Bacteroides fragilis The degree of resistance is determined by IS (insertion sequences) elements, which serves as promotors for the cfia gene 5 Sóki et al. J Med Microbiol. 2004

Metronidazole mechanism of action Metronidalzole is reduced by ferredoxin to toxic metabolites (only in anaerobic cells) The toxic metabolites disrupts the DNA 6 Virkningsmekanisme

Metronidazole-resistance Rare, in otherwise susceptible species (Bacteroides, Prevotella, Clostridium) Resistance mechanism: nim genes (A-J) encodes a nitroimidazole reductase chromosomal or on a plasmid The nitroimidazole reductase converts metronidazole to non-toxic metabolites 7 The prescense of a nim gene is NOT equal to resistance and resistance is NOT equal to the prescense of a nim gene

Phenotypic tests the Gold standard Agar dilution for MICs Impossible in a routine laboratory 8

Phenotypic tests Screening with disk diffusion (some crazy labs)!!! Gradient strips (breakpoints according to EUCAST) Meropenem-EDTA or imipenem-edta doubble-etest demonstrate MBL (cfia mediated?) Bacteroides fragilis ATCC 25285 9 Bacteroides fragilis ATCC 25285 MBL+ Bacteroides fragilis

Pseudo metronidazole-resistance Clostridium perfringens DSM 25589 Metronidazole resistance in the laboratory is very often caused by insufficient anaerobic conditions Oxygen in the anaerobic atmosphere 10 Metronidazole is NOT reduced to toxic metabolites Justesen et al. Diagn Microbiol Infect Dis. 2013.

The new methods for detecting resistance MALDI-TOF Whole genome sequencing (WGS) 11

Methods available for antimicrobial susceptibility testing with MALDI-TOF 1) Demonstrating a genotype = resistance (e.g. the meca gene) 2) Demonstrating break down of an antibiotic (e.g. hydrolysis by a beta-lactamase) 12 3) Demonstrating bacterial growth 4) Demonstrating bacterial kill

2) Demonstrating break down of an antibiotic MALDI-TOF hydrolysis assay Beta-lactam antibiotics, in this case carbapenems, are hydrolysed by the metallo-betalactamase encoded by the cfia gene in B. fragilis 13 Hydrolysis results in mass changes of beta-lactams, which can be measured by MALDI-TOF

MALDI-TOF hydrolysis assay Start here 14 Johansson et al. Anaerobe. 2014

MALDI-TOF hydrolyse assay Imipenem R > 8 mg/l Ertapenem R > 1 mg/l 15 Johansson et al. Anaerobe. 2014

Not quite there with MALDI-TOF yet! The presence of beta-lactam hydrolysis is not always equal to betalactam resistance in the presented examples with B. fragilis 16 We need more

3) & 4) Demonstrating bacterial growth/kill - with the MALDI BioTyper Antibiotic Susceptibility Test Rapid Assay MBT-ASTRA 17

Workflow MBT-ASTRA The boxes = variables Broth? McFarland ##? Antibiotic concentration ##? Incubation 35-37 C (?) Species dependent ##? time Cell lysis Lysis reagent with internal standard (IS) 18 Target preparation Acquisition of MS profile spectra

Intensity Intensity Intensity Intensity MBT-ASTRA measuring the AUC SUSCEPTIBLE STRAIN RESISTANT STRAIN IS Bacteria IS Broth only IS Bacteria IS Mass Mass 19 IS Bacteria IS Broth + antibiotic IS Bacteria IS Mass Mass IS = internal standard

MBT-ASTRA and Bacteroides fragilis ATCC 25285* Results Broth only Metronidazole 4 mg/l 20 Metronidazole 8 mg/l Metronidazole 32 mg/l BB: Brucella broth MTZ: metronidazole *B. fragilis ATCC 25285 is fully suscpetible to metronidazole

MBT-ASTRA and Bacteroides fragilis Resistant and suscpetible can we detect a difference? Broth only Pip-tazobactam 128 mg/l Broth only 21 Pip-tazobactam 128 mg/l Resistant Susceptible BB: Brucella broth TZP: piperacillin-tazobactam

Still some work ahead Quantifying the level of resistance from the AUC Isolates close to the breakpoint will probably be a challenge! 22

A few cases with a little WGS 23

Case: Abscess with B. fragilis Akershus universitetssykehus HF MIC (mg/l) Meropenem: >256 Piperacillin-tazobactam >256 Clindamycin >32 Metronidazol >32 24 imipenem-edta og meropenem-edta doubble-etest POSITIVE (Ratio 8) Mechanisms?

WGS workflow for dummies 25 Sample on machine Data from machine

TGTCGCTTTCAGGTCACCAGTACCTGAACCTAAGGCCGGCACTTCGATAACAGCTTGATTGTAAGACAGCACATTTACCCCTTCCGTATATTTAGACTCCTGGTTGAAACCGGCCATTACGCTAAAATGGTGGTCTTTCTTAATATCAAACTTATATGTACCATAAATATTGAAGGCATTGTAATCGGTG AACTGTTTTTCTTTCTGCAAATAGTCTTTTGCAGCATTCCAGATGTTGTTACCTCCCTGTATGTCTGTATACTGAGTTTTTCCGGTATAGAAATTATAGTCATACATGTTTTTGTCAAACGTGTATTCAAATACCCCTTCAAAGCCTTTGAATGGCTTCAAAATAGATTTCACGAAAACACGCGGATTGTCAT ATGACTTTTTCCATTTATTCGCCAACAACACCTGATTACGCGGTGTATTGAAAGGCAAATCCTGAGAGATTGTAGAACAAACGTCCGCAGGCATATTACCTTCCGGTTGATAAGAAACCTGATTACTACCGAACATGCTTCCCAGACCGGAACTCGGTTGTGACTGATTGGTACGCGCATAGCTCATTG TCAGTTCCTGAGTAAACCATTTGGTAATATCAGCAGAAATATAAGAATTGATATTCAGACGTTCATACGTATCTTTATCGGTAATCAAAACACCGTCCGTAGATACATATCCGGCTGACATACGGTAACGCAACTTATCTGTACCGCCGGATACAGAAAGATTATGATTCATCTGGAAACTGGTCTCCAT AAAATTCTTATATGGATCATGTTCGTTCAGATAATACAAGGCTCCGTCCGTATCGGCAAAAATACCATCACCTACAGTTTTGATAGATGAAGGATCCTGCCTGTACTGTGTCAGGTATTCCTTCCATTTTGAAACACTGGGTGAACCATAAGACCAATAAGCATCAGAATATCCTCCATCCTGATAAGCC TGCAGGTAATCCATTAACGATGCTTGCTTCGGCAGATTCATTGCAGTAGCAAAACCGAAATTATTGTTATAGTTCAGGCGGAAAGCCGTAGCTTCTTTCGGGCGCTTAGTAGTCACCAAAACCACACCACCGGCCGCACGCGCACCATAAATAGCTGCCGAAGCAGCATCTTTCAGTACCGTCACCG TTTCGATATCTTCCGGATTCAACATGTCGAGGCTACCCTCTACGTTATCAATCAAGATAAGAGGCGCGACATTGGCACCATAGCTTCCGTCGCTATTCTTGATACCTACTGAATAGGCACCACGCAGTTGGAATGACTTTCCGCTACCCGGTGCATTCCCGCTATTAGATACCAGCAGTCCCGGAACC GTACCTTGCAATGCATCGGAAGCTGTCATAATAGGACGGTCCCCGATAATCTCATCCATTTTGATAGATGAAACAGCACCTGTCAAGTTTGCTTTCTTTTGTGAACCGAAACCGACTACCACTACTTCGTCTAAGGTACGAGAGTCATCTTTCAGCACTATCTTCAAAGGAACACCGGCCACGGCTTTC ACTTCTTGTGTTACATAACCGATATAAGAGATAACGATAACAGCACCCGGATTTACCGACAAAGAGAAATTTCCCTCTACATTACTGATCGTACCATTCTGGGCATTGTTTTTTTCCATAATGGTAGCACCAATAATCGATTCTCCCAGGTTATCCCTGATATTACCTTTTACAACGATCTTATTACTCTGC TGTGGTGTGGAAACTACCTCCGGAGCACTCTTCAGAATAACTTCATTGCCCTTGATGACATAGCTGATACCACTGTCTTTAAACAGCACATTCAGTACCTCCTCTATGGAGCCTTCACAATTGATGTCACGGATCTTTGCATTACCCAAATCGGCTGCCTTGTAAAAGAACGTATATTTACTGTTCTTTT CAATAACCTGGATGGCCTGTTTAATGCTCATTGCCTTTCCCTGCACGGCTATCTGTCCCTGCACGGCAAAAACGGACATAGGATACAGGAGCATAAACATAATTACGCCTGCCAGAAAACGCCTGTTACAGACGCTAAAACATTGTCTCATGTCTTTCATTTTTTTGATTATACGATTAATTAGTGATTG ATAAAAAAGCGATTATTTATAAATAATGATTCTCTGTGTTTCTTTTCTAAATTTCAAATTCATATTGATACAAATCTTTTCGATAACTTTAGATGCGGGGTCATCATAACGCATATAGCCTGTGAACAAGTCATTTCGGGATACTTTCTCGTCGAGCTCTACCGGAATATGGTAAATATCATGAATGGCTTCT ATCAAATCATCCATACGCATGTCGACAAATTTGTAACGTCCCTCATCCCAACTGATATTACCTATATTCTTTAATATCACTTCATCCTTTTCGGGATGAAAAATAATCTGTTGCAAAGGTTTCATTTCAATCTTCCTCTGCGAAGCCTTAGCGTTGAAATCAACCTTTCCACTAAAAAGAGTCACTTCCGCA CCATACTGCCGGGTGGACTGAACACGAAAAACCGTCCCTTTGACTTCTACAAATGCCTGATCAATATATACCTTAAAATTACGTCCCTTACGTTTGGTTACCTCAAAAGTAGACTCTCCCTCCAACCAGACTTCCCGTTTATCCATAAAGTCCTGTGAAAAACGGATTCGACTTCCGGCTTGCATCCAA ACCCTTGAACTGTCGGGGAGCACGTACAACCGGCTATTTGAAGAAACAATCTCAGTATACTCAATGATATGTTGCGAAGTGACAGGCTCCTCATTAAAAAAGAAGATACTTCCCCCAACAACCAATAACACTGTAATACATGCAGCGAGAGCAATCTTCAAGTACCTGAGCTGGAGCCGTTGCTTACG TTCAAAAGGAGTCTGACATTTGGAATCAATCTTATTCCAAATCCTACTTTCAACAGCAGCATCATCCACTATATTCCTTGCAGCATCAAATTGTTTTTTCATCTTTGTCTCCACAACATCCCAGTGCGCCAGCTCTTCTACTTCTCCCGGAGAAGACTTACCGGCAATCAATTTGCGGACAAGCCGATCG TATTTATTAGAAATCTTCATATTCTTTATATTTCTTTCCAAAAGCCCAAGCTATATTTATAAATCTATCCATAAATACACAATTTATAAAATTCCCCCCTATATGTTTTCCGCTTTTTTTCTGTTTTATAAATTGAGTATGCTATATTTGTAATCCAAACGTAACTCTTAATGAACGAAAAAGAAGCAATTATTAA ACTGAAGACCCGCAATGATAAAGCTGCCTTTGCATTCCTGTACCACTCTTATTGGGCTAAGGTTTACAACTTTACGCGACTTTATGTCACTTCTTTGGTTGATGTGGAGGAAATCGTTCAAGAGGTTTTTATTAAAATCTGGGAGAGCAGAGAGTCTTTGGATGAAGAGCAAAACTTTGCAGGATATCTG TTCATCACCATGCGTAACCTTGTTTTTAACCGCTCCCGCAAGAATCTGAACGAGGCTTTCTACCAACTGTCAGTGATAGAAGCAGTAGAAGAGTCATATGATATAGAAGAAGAACTGGATGCAGCCAATCTACGGACACATATCGAATCACTTATTTCAATGTTACCACCCCGGCAACAGGAAGTATTC CGTCTGAGCAGGGACGAAGAACTTTCTTATCGTGAAATTGCAGAGAAACTGCAAATATCGGAAAGAACAGTGGAACACCACATATCCGATGCTTTGAAGTTTCTAAGAAAAAACATCAAGCTTTACACATTATTCCTTTCATTATAAATGAAGTAGCGCTGCTCTTCCCCGTTGGGACAGAACAGCGCC GATCATCAGTTTTTTATGAAAAACGAAACTTTCTTTCATAGAGAGGTATTACACTTACATAACAATTCTCTCTTCACAGAGATACTATTAACACTATATATAAACATGATGATTTTCATTAATAAATCAAAAATAAACATTTCTATAAAAATAAGAAATGGAAATCGACTAATAGAACAATTTAATCGATCAAAA TGTTCTCTACATTTTCAGTAAACGTTTACTCAAATACCTTACCGGATACCAGACAGATAAAAATCCGACAGTAAATACGGTAATAAATATCACGATGACATCCCCCAAATGAACACTGACCGGATAGGAATCAACTACAAAATTACCTGCAGCATTACCTCCACCCAATGAAACTATCCCGTAGGCCATC TGAACCCAACATAGAACCAAGCCGAGTATAATCCCGATTATAGCCCCATAAAAGGAAATCATACATCCTTCGAAAAGGAAAATACGCGAAACAAGCCGATCGTCAGCTCCCAATTTACGAAGTGTATTCACATCTTCCTTTTTATCCAGAATAAGCATCGACAGCGAACCTATCACATTGAAACAGGCG ATCACGAGAATAAAGGTAAGAAACAAATACGAAACCAATTTCTCTATCTCCATGATGCGAAACACATCCTCCTGCTGCTCGTAACGGTTACGAATAACAAAACCATCTCCTAACGCCTTCCCGATCTTTTCTTTCACTACAGAAATATTAGATCCCGGCTTTAGTTTCAGTTCTATTGCAGACACTTCGGT AGTATAATCAAGCAAACGCCGGGCAAAATCCAACGAAGTGAGAATATACTGTCCGTCATACTTCTGCTGATTGACTACAAACACTACACCGGGCGAATACAAATAATCCATATTAAAGGAAGCAGCCGGATTTGCAAGATTAACCTTTCCATTCCTTTTAGGAATATATACCTGCAAAGGATCGACAAA CCTGATTCCGGTCCCCAATGTAGAGACAAGCTCAATCCCCATCACTCCATAATCCACAACAGAATCGTTCAACAAAAACTCACCTGCTCCATAAAGGATACTATCTATTGCAGTCAACTGCTCAAAATTATCTTGTACCCCCTTTATAACAGCCATTGTTTGACGATCCTTGTATTGCACCATCGCATTC TCTTCAAGTGTTTCAGTCAACACATCTACTTCCGGCATCTGCCGGATAGCCTGAATACGCGGGTCCTGTGCATCGAAAACTTTCCCTTCGGCAATCGTCACTTTCAGTTCCGGATCAAACACAGTAAACAGATCGGCTACTGTATCCTGAAAACCATTGAATACGGAAAGTGTACACACCATTGCCATC GTAGCCAATGCTACTCCACACACGGAAATAGCCGAAATGATATTAATGGCATTGTGTTTCTTCTTTGAGAAAAGATATCGCCGGGCTATGTAGAAGGGAAGATTCACTTCAACAAGGCATCTATCTTTTCAATGTAGTCCAGCGAATCGTCCACAAAAAATTTCAATTCGGGGATAATACGCAACTGAT GACGAACACGGGTACCGAGTTCGAAACGGATGGACTTCATATTATTATTGATATTCTTTACCATTTCTTCGCTTTTATCAGAAGGGAAGACACTTAAATATACGCGGGCAATGCTCATATCAGGGCTGATACGTACAGCACTGACAGATACCAACACACCGGGCATGGCCTTGGTCTGCAACAGAAAA ATCTCACTGAGTTCTTTCTGTAACAAACGGGCTATCTTATTCTGTCTCGTTGTTTCCATAAACTTTCTACGTAATTATTTTATCAAACAAGCAATTAGCACTTGTTACAATAGAACACAAAATTAGAGAAATATATCGTTTGACAGATAAAATATGTACTATTTTTAATCTTCATTATTGAATTATTCTTCCAAT GCTAAAGAGTAATCAACTAATACACATCTCACTTTTTACGAATAATGGTCAGTCCATCACGCAAAGGGAGGATTACTTTCTCCACTCGTTCATCATGTGCCACCAATTCGTTGAAAGCCTTAATACCGATGGTTTGATAGTCGTTGTTATGTGGCTCTTCCAGCACATGACCATCCCATAAAGTGTTATC GGCTATGATATATCCTCCGGGAGAAAGATGCGCAAGAGTCATCTCATAATATTCAATATACTTACGTTTATCGCCATCCACAAAAGCAAGGTCAAACGTAACTCCCAATGCAGGTATCAATTGGAGAGCATCTCCAATGTAGAATTTAATTTTATCAGCATAAGCTGAATTTTCGAGCCAGGGACGGGT AAAGTCTTCCTGTTCGTCATTTATCTCAAATGTGTGGAGCATTCCACCCTCCTCAAGTCCTTCGGCCAAGCAAAGGGCGGAATAGCCACTATAAGTTCCTATTTCTAATATCTGGCGAGGCCGTATCATACGAACAAACATCTTCAACATACGCCCCTGCAGATGACCGGAAGCCATACGGGGACGCA GAAGCTTGACATGCGTATCCCGATAAAGAGCTTTCAGGTATTCACCTTCTTCATCGATATGCTTTAGGATATATTCGTCTAAAAGATCGGTCTCTTTCATCTCATCCTACAGATAACGGTTGCTGTTAGGCAATACACTGTCACCGGCATGCTTCAAAGCATCTTCCACGACATTGATCTCAAGGAAAGA GGTTTGTGTCCCGGCTTTACCGCTACTCAGATAACCCACCATATCAGTAGGATGTAAACGTCCTTCTTTCAATAAACGACGCAGAGCGGCAAAATAATACTCCTGTCCGTTGGCCAACTCAGGCATGTAGATCGCCTCCACTCCATAAGAGAGTGCCAGGTGACGCATCGTTTTCTCCTTATAACAAA TGGCAAGCACCGGATATTTACCACGGAAAGCAGCCAGATTACGTGCAGTGCGCCCTTGATAGCTATCAGTAATGATAGCGCGTATTTTTAGTTTAGTAGTTGCTTTCACAGCCTGTTTGGCAAGGAAAGCAGTCACGTCATTACTATTCTCATCCAGAGGAATACGGATATCATTTTCTTCCAATTTGTC TTTTTCAGCCTGTGCAGCAATCTTAGTCATGGTTTTCACAGCCTCCACCGGATATTTACCATACGCGGTTTCACCACTCAACATCAGAGCATCCGTACGATAATAGATAGCATTCGCAATATCGGTTACTTCAGCACGAGTCGGACGCGGATTATTTATCATCGTATGTAACATCTGTGTAGCTACGATT ACCGGCTTCTTGGCAAGAATACATTTACGTATCAATGTACGCTGAATTCCCGGAATGCGTTCCTGTGGAACTTCAATACCCAAGTCACCGCGAGCTACCATCACTCCATCAGCAACTTCCAGAATCTCATCTATATTATCTACACCTTCTTGATTCTCTATCTTAGCAATAATACGGATATCGCTGTTGT GTGCATCCAGAATTTCACGAATATCAAGCACATCCTGACGGTTACGTACAAAAGAATGTGCTATGAAATCGATATCTTTTTCTATCGCATAAAGAATGTTATTACGATCTTTTTCAGTCAGAGAAGGCAGGTTGATGCGGACCCCGGGAACATTTACACTCTTACGGCTCCCCAAGGTTGCTTCATTCTG CACCTCACAAAGTAAATATTCGGACGTTTTATCAATAACCCGCAACTCAAGATCACCATCGTCAATCAAAATAGTTCCACCTATATTCAGATCGTGTACGAAATTCGGATAAGAAACGGCAATACATTCACGGGTAGTCTCACGTTCGGGATCCCCCACAATTTTAACCTTCTCGCCAATCTGATAAAGT ATTGGTTCCGCATTGGCAGTGGTACGTACCTCCGGACCTTTAGTATCCATAAGGATAGCGATGCGATTGGACACGGTACGAACATTGGCAATCAACGCTTCAAACCCTTCACGACTGGCGTGAGCTGTGTTCATACGAACCACATTCATCCCTGCATCAAACAACTCTTTTATAAAATCTACATCGCA ACGTCTGTCTGAGATGGAAGCTACGATTTTAGTCTGTTTCAGCAACATAATCTATCTACCTATTTATATTTATACCTATTTATCTAATAAAGCCTCAAGTGCCAGACGATATGAGTTCAATCCAAATCCACAAATCACACCTTTACAGGCACAAGCAATCATAGAAACATGACGGAACGACTCGCGGGCAT GAACATTGGAAATATGAACCTCAATCACAGGAGAGGGAACGGAACGGATGGCATCCTGCAAAGCAATGGAAGTGTGCGTATAAGCTCCTGCATTCAAAATGATTCCATCCACATCGAAACCGGTCTGCTGAATTTTATCTATCATTTCTCCTTCAACGTTCGACTGGAAATAACCCAACTCCACATCG GGATATTTTTTACGAAGCTCACCTAAATACTCTTCAAATGTAACGCTTCCATATATAGAAGGTTCACGCTTGCCCAAAAGATTAATATTGGGACCATTAATAATTTGTATCCTCATAACACAATCCTGCTATTTTTAATACCTTTGTCTTCGAGAACAATATTTCAAGATGCAAAGGTAGAAAAAAGAAATGA AATTAGACGAAAAAACAAAAAAGAAGGATGTGCAAGGGTTGATTATCAAAAAGTACCAACAGTATCTGAAACTGGAAAAGTCATTATCCGAAAACACATTGGATGCTTATTTGACGGATTTGGACAAGCTATTGAACTTTTTATCGGCCGAAGGTGTGGATATACTGGAAATCAGCCTGAAAGACCTTCA GCGTTTTGCAGCCGGACTGCATGATATCGGTATCCATGCCCGGTCACAGGCACGCATCATTTCCGGCATCAAGTCTTTCTTCCATTTTCTGATAATGGCCGATTATATAGAAGCTGATCCGAGTGAATTACTGGAAGGTCCCAAGATTGGTTTTAAACTACCGGAAGTATTGACTGTAGAGGAAATAGA CCGTATCATCTCAACTGTAGATCTGAGCAAAAATGAGGGACAGCGAAATCGGGCAATATTGGAGACACTCTATAGCTGTGGTTTACGGGTTTCGGAATTAACCAACTTAAAACTATCAGATCTTTATTTTAATGAAGGATTCATTAAAGTAGAAGGAAAAGGTAGTAAACAACGATTGGTGCCCATCTCC CCCAGAGCCATTCAGGAAATAAAATACTATTTCATGGATCGAAACCGGATTAACATAAAAAAAGATTATGAGGATTATCTGTTTTTAAGCAGACGGGGAACACACCTATCACGTATCATGATCTTTCATCTTATCAAAGAACTGGCCGATATGGCAGGTATCACCAAAAACATCAGTCCACACACATTCC GGCATTCTTTCGCAACACACCTTCTTGAAGGAGGCGCCAACCTGAGAGCTATTCAATGCATGCTCGGACATGAATCAATTTCGACCACCGAGATTTACACACATATCGACCGTAATATGCTGCGAAGTGAAATCATAGAACACCATCCGCGCAACATCAAATATCGGCAAGAAAAAAGGCATTTCAAT AAACAATAAAGTCTGGTTTGGCGTTATTTAGAGAGAGAAATAGTGCTGAACAGCTCAGGAATGCGACAGTTTTCATTAAATTATAATAAAATTAAGGGTGTATTTGCCTAAATGTATAAGAATTAATATCTTTGCGTGGCATTTATGGGCAATCCACAGATGCGTATTGAATAGACAAAATTTCAATTACAA ACATTTAATTTATACCTAAAATGATCAAGAAGTTGTATTTGCCTTTACTTATGGCATTGGTTGTTGCATTGTCATCATGTAGCAACAAAATGGGTGCACTGTCATCTGATTACTTCACTACGACTCCTCAGGTACTGGAAGCTGTAGGTGGTAAAGTTCCTGTGACTATCAACGGAAAGTTCCCTGAAAAG TATTTCAAAAAGAACGCAGTTGTTGAAGTAACTCCGGTCCTGAAATGGGAAGGTGGACAAGTGAAAGGACAGCCTGCTGTATTCCAGGGTGAAAAGGTAGAAGGTAACGACCAGACTATCTCTTACAAGATGGGTGGTAATTACACGATGAAAACTACATTCGACTATGTTCCTGAAATGGCTAAGTC TGAACTGTACCTTGAATTCAACGCAAAAGTTGGAAAAAAAACAATCGCTATCCCTGCAGTGAAGATCGCAGACGGTGTGATCTCTACTTCTGAATTGATTAACAATACTTTGAGCAGCGCTAATCCGGCTTTGGGTGACGACGCTTTCCAACGTATCATCAAAGAAGCACACAACGCTAACATCATGTT CCTTATCCAACAGGCTAACATCCGTTCAAGCGAATTGAAAACCGCTAAGGAATTCAACAAGGAAGTTGCTAACGTAAACGATGCAGAAAACAAAAAGATCAGCAATATCGAAATTTCGGCTTATGCTTCTCCTGATGGTGGTGTGAAACTGAACACAGGTTTAGCTGAGAACCGTGAAGGTAACACTA CTAAACTGATCAATAAAGACCTGAAGAAAGCTAAAATCGAAGTTCCGGTTGATGCTAAATATACTGCTCAAGACTGGGAAGGTTTCCAGGAACTGGTTTCTAAATCAAACATTCAGGATAAAGAACTGATTCTTCGTGTTCTGTCTATGTATCAGGATCCGGAACAAAGAGAGACAGAAATCAAAAACAT CTCTTCTGTATACAAAACTTTGGCTGACGAAATCCTGCCGCAGTTGCGTCGTTCTCGTTTGACTTTGAACTATGAAATCATCGGTAAGTCTGATGAAGAAATCGCTAATCTGGCTGCAACAGATCCGAAACAGTTGAATCTGGAAGAAATCCTGTATGCTGCTACACTGACTAACGACCCGGCTAAGAA AGCTGACATCTATACAAAAGCTTCTCAGCAGTTCCCGAATGACTACCGTGCATTCAACAACTTGGGTAAACTGGCTTATCAAGCAGGTGATTTGGACAAGGCTCAATCATACGTGAAAAAAGCAGAAAGCATTAAAGCTGCTCCTGAAGTAAACATGAACTTAGGTTTGATCGCTCTGGCTAAGGGTG ACAAAGCTGCTGCTGAGTCATACTTAGGTAAAGCTGCCGGTGCTAAAGAACTGAACGAAACATTGGGTAACCTGTACGTAGCTCAGGGACAATACGAAAGAGCAGTAAACGCATTTGGAGACACTAAAACAAACAGTGCTGCTTTGGCACAGATCCTGGCTAAGGACTACAACAAAGCTAAAAACAC TTTGGCTGGTATCTCAACTCCGGATGCTTACACA 0.2% of data from the machine Put data in to big computer Push button on big computer 26

Results from big computer (B. fragilis) 27

Case: Blood culture with B. fragilis Mikrobiologen, Sunderby sjukhus, Luleå MIC (mg/l) Imipenem: 12 Meropenem: >256 Piperacillin-tazobactam >256 28 Clindamycin 2 Metronidazol 0.25 imipenem-edta doubble-etest NEGATIVE!? Mechanism?

Phenotypic tests Meropenem-EDTA or imipenem-edta doubble-etest to demonstrate MBL which one? 29 MALDI-TOF with the right peaks cfia+

Case: Blood culture with Parabcteroides goldstenii Odense Universitetshospital MIC (mg/l) Meropenem: >256 Piperacillin-tazobactam >256 30 Clindamycin >32 Metronidazol 0.25 imipenem-edta og meropenem-edta doubble-etest POSITIVE (Ratio 8) Mechanisms?

WGS workflow for dummies 31 Sample on machine Data from machine

TGTCGCTTTCAGGTCACCAGTACCTGAACCTAAGGCCGGCACTTCGATAACAGCTTGATTGTAAGACAGCACATTTACCCCTTCCGTATATTTAGACTCCTGGTTGAAACCGGCCATTACGCTAAAATGGTGGTCTTTCTTAATATCAAACTTATATGTACCATAAATATTGAAGGCATTGTAATCGGTG AACTGTTTTTCTTTCTGCAAATAGTCTTTTGCAGCATTCCAGATGTTGTTACCTCCCTGTATGTCTGTATACTGAGTTTTTCCGGTATAGAAATTATAGTCATACATGTTTTTGTCAAACGTGTATTCAAATACCCCTTCAAAGCCTTTGAATGGCTTCAAAATAGATTTCACGAAAACACGCGGATTGTCAT ATGACTTTTTCCATTTATTCGCCAACAACACCTGATTACGCGGTGTATTGAAAGGCAAATCCTGAGAGATTGTAGAACAAACGTCCGCAGGCATATTACCTTCCGGTTGATAAGAAACCTGATTACTACCGAACATGCTTCCCAGACCGGAACTCGGTTGTGACTGATTGGTACGCGCATAGCTCATTG TCAGTTCCTGAGTAAACCATTTGGTAATATCAGCAGAAATATAAGAATTGATATTCAGACGTTCATACGTATCTTTATCGGTAATCAAAACACCGTCCGTAGATACATATCCGGCTGACATACGGTAACGCAACTTATCTGTACCGCCGGATACAGAAAGATTATGATTCATCTGGAAACTGGTCTCCAT AAAATTCTTATATGGATCATGTTCGTTCAGATAATACAAGGCTCCGTCCGTATCGGCAAAAATACCATCACCTACAGTTTTGATAGATGAAGGATCCTGCCTGTACTGTGTCAGGTATTCCTTCCATTTTGAAACACTGGGTGAACCATAAGACCAATAAGCATCAGAATATCCTCCATCCTGATAAGCC TGCAGGTAATCCATTAACGATGCTTGCTTCGGCAGATTCATTGCAGTAGCAAAACCGAAATTATTGTTATAGTTCAGGCGGAAAGCCGTAGCTTCTTTCGGGCGCTTAGTAGTCACCAAAACCACACCACCGGCCGCACGCGCACCATAAATAGCTGCCGAAGCAGCATCTTTCAGTACCGTCACCG TTTCGATATCTTCCGGATTCAACATGTCGAGGCTACCCTCTACGTTATCAATCAAGATAAGAGGCGCGACATTGGCACCATAGCTTCCGTCGCTATTCTTGATACCTACTGAATAGGCACCACGCAGTTGGAATGACTTTCCGCTACCCGGTGCATTCCCGCTATTAGATACCAGCAGTCCCGGAACC GTACCTTGCAATGCATCGGAAGCTGTCATAATAGGACGGTCCCCGATAATCTCATCCATTTTGATAGATGAAACAGCACCTGTCAAGTTTGCTTTCTTTTGTGAACCGAAACCGACTACCACTACTTCGTCTAAGGTACGAGAGTCATCTTTCAGCACTATCTTCAAAGGAACACCGGCCACGGCTTTC ACTTCTTGTGTTACATAACCGATATAAGAGATAACGATAACAGCACCCGGATTTACCGACAAAGAGAAATTTCCCTCTACATTACTGATCGTACCATTCTGGGCATTGTTTTTTTCCATAATGGTAGCACCAATAATCGATTCTCCCAGGTTATCCCTGATATTACCTTTTACAACGATCTTATTACTCTGC TGTGGTGTGGAAACTACCTCCGGAGCACTCTTCAGAATAACTTCATTGCCCTTGATGACATAGCTGATACCACTGTCTTTAAACAGCACATTCAGTACCTCCTCTATGGAGCCTTCACAATTGATGTCACGGATCTTTGCATTACCCAAATCGGCTGCCTTGTAAAAGAACGTATATTTACTGTTCTTTT CAATAACCTGGATGGCCTGTTTAATGCTCATTGCCTTTCCCTGCACGGCTATCTGTCCCTGCACGGCAAAAACGGACATAGGATACAGGAGCATAAACATAATTACGCCTGCCAGAAAACGCCTGTTACAGACGCTAAAACATTGTCTCATGTCTTTCATTTTTTTGATTATACGATTAATTAGTGATTG ATAAAAAAGCGATTATTTATAAATAATGATTCTCTGTGTTTCTTTTCTAAATTTCAAATTCATATTGATACAAATCTTTTCGATAACTTTAGATGCGGGGTCATCATAACGCATATAGCCTGTGAACAAGTCATTTCGGGATACTTTCTCGTCGAGCTCTACCGGAATATGGTAAATATCATGAATGGCTTCT ATCAAATCATCCATACGCATGTCGACAAATTTGTAACGTCCCTCATCCCAACTGATATTACCTATATTCTTTAATATCACTTCATCCTTTTCGGGATGAAAAATAATCTGTTGCAAAGGTTTCATTTCAATCTTCCTCTGCGAAGCCTTAGCGTTGAAATCAACCTTTCCACTAAAAAGAGTCACTTCCGCA CCATACTGCCGGGTGGACTGAACACGAAAAACCGTCCCTTTGACTTCTACAAATGCCTGATCAATATATACCTTAAAATTACGTCCCTTACGTTTGGTTACCTCAAAAGTAGACTCTCCCTCCAACCAGACTTCCCGTTTATCCATAAAGTCCTGTGAAAAACGGATTCGACTTCCGGCTTGCATCCAA ACCCTTGAACTGTCGGGGAGCACGTACAACCGGCTATTTGAAGAAACAATCTCAGTATACTCAATGATATGTTGCGAAGTGACAGGCTCCTCATTAAAAAAGAAGATACTTCCCCCAACAACCAATAACACTGTAATACATGCAGCGAGAGCAATCTTCAAGTACCTGAGCTGGAGCCGTTGCTTACG TTCAAAAGGAGTCTGACATTTGGAATCAATCTTATTCCAAATCCTACTTTCAACAGCAGCATCATCCACTATATTCCTTGCAGCATCAAATTGTTTTTTCATCTTTGTCTCCACAACATCCCAGTGCGCCAGCTCTTCTACTTCTCCCGGAGAAGACTTACCGGCAATCAATTTGCGGACAAGCCGATCG TATTTATTAGAAATCTTCATATTCTTTATATTTCTTTCCAAAAGCCCAAGCTATATTTATAAATCTATCCATAAATACACAATTTATAAAATTCCCCCCTATATGTTTTCCGCTTTTTTTCTGTTTTATAAATTGAGTATGCTATATTTGTAATCCAAACGTAACTCTTAATGAACGAAAAAGAAGCAATTATTAA ACTGAAGACCCGCAATGATAAAGCTGCCTTTGCATTCCTGTACCACTCTTATTGGGCTAAGGTTTACAACTTTACGCGACTTTATGTCACTTCTTTGGTTGATGTGGAGGAAATCGTTCAAGAGGTTTTTATTAAAATCTGGGAGAGCAGAGAGTCTTTGGATGAAGAGCAAAACTTTGCAGGATATCTG TTCATCACCATGCGTAACCTTGTTTTTAACCGCTCCCGCAAGAATCTGAACGAGGCTTTCTACCAACTGTCAGTGATAGAAGCAGTAGAAGAGTCATATGATATAGAAGAAGAACTGGATGCAGCCAATCTACGGACACATATCGAATCACTTATTTCAATGTTACCACCCCGGCAACAGGAAGTATTC CGTCTGAGCAGGGACGAAGAACTTTCTTATCGTGAAATTGCAGAGAAACTGCAAATATCGGAAAGAACAGTGGAACACCACATATCCGATGCTTTGAAGTTTCTAAGAAAAAACATCAAGCTTTACACATTATTCCTTTCATTATAAATGAAGTAGCGCTGCTCTTCCCCGTTGGGACAGAACAGCGCC GATCATCAGTTTTTTATGAAAAACGAAACTTTCTTTCATAGAGAGGTATTACACTTACATAACAATTCTCTCTTCACAGAGATACTATTAACACTATATATAAACATGATGATTTTCATTAATAAATCAAAAATAAACATTTCTATAAAAATAAGAAATGGAAATCGACTAATAGAACAATTTAATCGATCAAAA TGTTCTCTACATTTTCAGTAAACGTTTACTCAAATACCTTACCGGATACCAGACAGATAAAAATCCGACAGTAAATACGGTAATAAATATCACGATGACATCCCCCAAATGAACACTGACCGGATAGGAATCAACTACAAAATTACCTGCAGCATTACCTCCACCCAATGAAACTATCCCGTAGGCCATC TGAACCCAACATAGAACCAAGCCGAGTATAATCCCGATTATAGCCCCATAAAAGGAAATCATACATCCTTCGAAAAGGAAAATACGCGAAACAAGCCGATCGTCAGCTCCCAATTTACGAAGTGTATTCACATCTTCCTTTTTATCCAGAATAAGCATCGACAGCGAACCTATCACATTGAAACAGGCG ATCACGAGAATAAAGGTAAGAAACAAATACGAAACCAATTTCTCTATCTCCATGATGCGAAACACATCCTCCTGCTGCTCGTAACGGTTACGAATAACAAAACCATCTCCTAACGCCTTCCCGATCTTTTCTTTCACTACAGAAATATTAGATCCCGGCTTTAGTTTCAGTTCTATTGCAGACACTTCGGT AGTATAATCAAGCAAACGCCGGGCAAAATCCAACGAAGTGAGAATATACTGTCCGTCATACTTCTGCTGATTGACTACAAACACTACACCGGGCGAATACAAATAATCCATATTAAAGGAAGCAGCCGGATTTGCAAGATTAACCTTTCCATTCCTTTTAGGAATATATACCTGCAAAGGATCGACAAA CCTGATTCCGGTCCCCAATGTAGAGACAAGCTCAATCCCCATCACTCCATAATCCACAACAGAATCGTTCAACAAAAACTCACCTGCTCCATAAAGGATACTATCTATTGCAGTCAACTGCTCAAAATTATCTTGTACCCCCTTTATAACAGCCATTGTTTGACGATCCTTGTATTGCACCATCGCATTC TCTTCAAGTGTTTCAGTCAACACATCTACTTCCGGCATCTGCCGGATAGCCTGAATACGCGGGTCCTGTGCATCGAAAACTTTCCCTTCGGCAATCGTCACTTTCAGTTCCGGATCAAACACAGTAAACAGATCGGCTACTGTATCCTGAAAACCATTGAATACGGAAAGTGTACACACCATTGCCATC GTAGCCAATGCTACTCCACACACGGAAATAGCCGAAATGATATTAATGGCATTGTGTTTCTTCTTTGAGAAAAGATATCGCCGGGCTATGTAGAAGGGAAGATTCACTTCAACAAGGCATCTATCTTTTCAATGTAGTCCAGCGAATCGTCCACAAAAAATTTCAATTCGGGGATAATACGCAACTGAT GACGAACACGGGTACCGAGTTCGAAACGGATGGACTTCATATTATTATTGATATTCTTTACCATTTCTTCGCTTTTATCAGAAGGGAAGACACTTAAATATACGCGGGCAATGCTCATATCAGGGCTGATACGTACAGCACTGACAGATACCAACACACCGGGCATGGCCTTGGTCTGCAACAGAAAA ATCTCACTGAGTTCTTTCTGTAACAAACGGGCTATCTTATTCTGTCTCGTTGTTTCCATAAACTTTCTACGTAATTATTTTATCAAACAAGCAATTAGCACTTGTTACAATAGAACACAAAATTAGAGAAATATATCGTTTGACAGATAAAATATGTACTATTTTTAATCTTCATTATTGAATTATTCTTCCAAT GCTAAAGAGTAATCAACTAATACACATCTCACTTTTTACGAATAATGGTCAGTCCATCACGCAAAGGGAGGATTACTTTCTCCACTCGTTCATCATGTGCCACCAATTCGTTGAAAGCCTTAATACCGATGGTTTGATAGTCGTTGTTATGTGGCTCTTCCAGCACATGACCATCCCATAAAGTGTTATC GGCTATGATATATCCTCCGGGAGAAAGATGCGCAAGAGTCATCTCATAATATTCAATATACTTACGTTTATCGCCATCCACAAAAGCAAGGTCAAACGTAACTCCCAATGCAGGTATCAATTGGAGAGCATCTCCAATGTAGAATTTAATTTTATCAGCATAAGCTGAATTTTCGAGCCAGGGACGGGT AAAGTCTTCCTGTTCGTCATTTATCTCAAATGTGTGGAGCATTCCACCCTCCTCAAGTCCTTCGGCCAAGCAAAGGGCGGAATAGCCACTATAAGTTCCTATTTCTAATATCTGGCGAGGCCGTATCATACGAACAAACATCTTCAACATACGCCCCTGCAGATGACCGGAAGCCATACGGGGACGCA GAAGCTTGACATGCGTATCCCGATAAAGAGCTTTCAGGTATTCACCTTCTTCATCGATATGCTTTAGGATATATTCGTCTAAAAGATCGGTCTCTTTCATCTCATCCTACAGATAACGGTTGCTGTTAGGCAATACACTGTCACCGGCATGCTTCAAAGCATCTTCCACGACATTGATCTCAAGGAAAGA GGTTTGTGTCCCGGCTTTACCGCTACTCAGATAACCCACCATATCAGTAGGATGTAAACGTCCTTCTTTCAATAAACGACGCAGAGCGGCAAAATAATACTCCTGTCCGTTGGCCAACTCAGGCATGTAGATCGCCTCCACTCCATAAGAGAGTGCCAGGTGACGCATCGTTTTCTCCTTATAACAAA TGGCAAGCACCGGATATTTACCACGGAAAGCAGCCAGATTACGTGCAGTGCGCCCTTGATAGCTATCAGTAATGATAGCGCGTATTTTTAGTTTAGTAGTTGCTTTCACAGCCTGTTTGGCAAGGAAAGCAGTCACGTCATTACTATTCTCATCCAGAGGAATACGGATATCATTTTCTTCCAATTTGTC TTTTTCAGCCTGTGCAGCAATCTTAGTCATGGTTTTCACAGCCTCCACCGGATATTTACCATACGCGGTTTCACCACTCAACATCAGAGCATCCGTACGATAATAGATAGCATTCGCAATATCGGTTACTTCAGCACGAGTCGGACGCGGATTATTTATCATCGTATGTAACATCTGTGTAGCTACGATT ACCGGCTTCTTGGCAAGAATACATTTACGTATCAATGTACGCTGAATTCCCGGAATGCGTTCCTGTGGAACTTCAATACCCAAGTCACCGCGAGCTACCATCACTCCATCAGCAACTTCCAGAATCTCATCTATATTATCTACACCTTCTTGATTCTCTATCTTAGCAATAATACGGATATCGCTGTTGT GTGCATCCAGAATTTCACGAATATCAAGCACATCCTGACGGTTACGTACAAAAGAATGTGCTATGAAATCGATATCTTTTTCTATCGCATAAAGAATGTTATTACGATCTTTTTCAGTCAGAGAAGGCAGGTTGATGCGGACCCCGGGAACATTTACACTCTTACGGCTCCCCAAGGTTGCTTCATTCTG CACCTCACAAAGTAAATATTCGGACGTTTTATCAATAACCCGCAACTCAAGATCACCATCGTCAATCAAAATAGTTCCACCTATATTCAGATCGTGTACGAAATTCGGATAAGAAACGGCAATACATTCACGGGTAGTCTCACGTTCGGGATCCCCCACAATTTTAACCTTCTCGCCAATCTGATAAAGT ATTGGTTCCGCATTGGCAGTGGTACGTACCTCCGGACCTTTAGTATCCATAAGGATAGCGATGCGATTGGACACGGTACGAACATTGGCAATCAACGCTTCAAACCCTTCACGACTGGCGTGAGCTGTGTTCATACGAACCACATTCATCCCTGCATCAAACAACTCTTTTATAAAATCTACATCGCA ACGTCTGTCTGAGATGGAAGCTACGATTTTAGTCTGTTTCAGCAACATAATCTATCTACCTATTTATATTTATACCTATTTATCTAATAAAGCCTCAAGTGCCAGACGATATGAGTTCAATCCAAATCCACAAATCACACCTTTACAGGCACAAGCAATCATAGAAACATGACGGAACGACTCGCGGGCAT GAACATTGGAAATATGAACCTCAATCACAGGAGAGGGAACGGAACGGATGGCATCCTGCAAAGCAATGGAAGTGTGCGTATAAGCTCCTGCATTCAAAATGATTCCATCCACATCGAAACCGGTCTGCTGAATTTTATCTATCATTTCTCCTTCAACGTTCGACTGGAAATAACCCAACTCCACATCG GGATATTTTTTACGAAGCTCACCTAAATACTCTTCAAATGTAACGCTTCCATATATAGAAGGTTCACGCTTGCCCAAAAGATTAATATTGGGACCATTAATAATTTGTATCCTCATAACACAATCCTGCTATTTTTAATACCTTTGTCTTCGAGAACAATATTTCAAGATGCAAAGGTAGAAAAAAGAAATGA AATTAGACGAAAAAACAAAAAAGAAGGATGTGCAAGGGTTGATTATCAAAAAGTACCAACAGTATCTGAAACTGGAAAAGTCATTATCCGAAAACACATTGGATGCTTATTTGACGGATTTGGACAAGCTATTGAACTTTTTATCGGCCGAAGGTGTGGATATACTGGAAATCAGCCTGAAAGACCTTCA GCGTTTTGCAGCCGGACTGCATGATATCGGTATCCATGCCCGGTCACAGGCACGCATCATTTCCGGCATCAAGTCTTTCTTCCATTTTCTGATAATGGCCGATTATATAGAAGCTGATCCGAGTGAATTACTGGAAGGTCCCAAGATTGGTTTTAAACTACCGGAAGTATTGACTGTAGAGGAAATAGA CCGTATCATCTCAACTGTAGATCTGAGCAAAAATGAGGGACAGCGAAATCGGGCAATATTGGAGACACTCTATAGCTGTGGTTTACGGGTTTCGGAATTAACCAACTTAAAACTATCAGATCTTTATTTTAATGAAGGATTCATTAAAGTAGAAGGAAAAGGTAGTAAACAACGATTGGTGCCCATCTCC CCCAGAGCCATTCAGGAAATAAAATACTATTTCATGGATCGAAACCGGATTAACATAAAAAAAGATTATGAGGATTATCTGTTTTTAAGCAGACGGGGAACACACCTATCACGTATCATGATCTTTCATCTTATCAAAGAACTGGCCGATATGGCAGGTATCACCAAAAACATCAGTCCACACACATTCC GGCATTCTTTCGCAACACACCTTCTTGAAGGAGGCGCCAACCTGAGAGCTATTCAATGCATGCTCGGACATGAATCAATTTCGACCACCGAGATTTACACACATATCGACCGTAATATGCTGCGAAGTGAAATCATAGAACACCATCCGCGCAACATCAAATATCGGCAAGAAAAAAGGCATTTCAAT AAACAATAAAGTCTGGTTTGGCGTTATTTAGAGAGAGAAATAGTGCTGAACAGCTCAGGAATGCGACAGTTTTCATTAAATTATAATAAAATTAAGGGTGTATTTGCCTAAATGTATAAGAATTAATATCTTTGCGTGGCATTTATGGGCAATCCACAGATGCGTATTGAATAGACAAAATTTCAATTACAA ACATTTAATTTATACCTAAAATGATCAAGAAGTTGTATTTGCCTTTACTTATGGCATTGGTTGTTGCATTGTCATCATGTAGCAACAAAATGGGTGCACTGTCATCTGATTACTTCACTACGACTCCTCAGGTACTGGAAGCTGTAGGTGGTAAAGTTCCTGTGACTATCAACGGAAAGTTCCCTGAAAAG TATTTCAAAAAGAACGCAGTTGTTGAAGTAACTCCGGTCCTGAAATGGGAAGGTGGACAAGTGAAAGGACAGCCTGCTGTATTCCAGGGTGAAAAGGTAGAAGGTAACGACCAGACTATCTCTTACAAGATGGGTGGTAATTACACGATGAAAACTACATTCGACTATGTTCCTGAAATGGCTAAGTC TGAACTGTACCTTGAATTCAACGCAAAAGTTGGAAAAAAAACAATCGCTATCCCTGCAGTGAAGATCGCAGACGGTGTGATCTCTACTTCTGAATTGATTAACAATACTTTGAGCAGCGCTAATCCGGCTTTGGGTGACGACGCTTTCCAACGTATCATCAAAGAAGCACACAACGCTAACATCATGTT CCTTATCCAACAGGCTAACATCCGTTCAAGCGAATTGAAAACCGCTAAGGAATTCAACAAGGAAGTTGCTAACGTAAACGATGCAGAAAACAAAAAGATCAGCAATATCGAAATTTCGGCTTATGCTTCTCCTGATGGTGGTGTGAAACTGAACACAGGTTTAGCTGAGAACCGTGAAGGTAACACTA CTAAACTGATCAATAAAGACCTGAAGAAAGCTAAAATCGAAGTTCCGGTTGATGCTAAATATACTGCTCAAGACTGGGAAGGTTTCCAGGAACTGGTTTCTAAATCAAACATTCAGGATAAAGAACTGATTCTTCGTGTTCTGTCTATGTATCAGGATCCGGAACAAAGAGAGACAGAAATCAAAAACAT CTCTTCTGTATACAAAACTTTGGCTGACGAAATCCTGCCGCAGTTGCGTCGTTCTCGTTTGACTTTGAACTATGAAATCATCGGTAAGTCTGATGAAGAAATCGCTAATCTGGCTGCAACAGATCCGAAACAGTTGAATCTGGAAGAAATCCTGTATGCTGCTACACTGACTAACGACCCGGCTAAGAA AGCTGACATCTATACAAAAGCTTCTCAGCAGTTCCCGAATGACTACCGTGCATTCAACAACTTGGGTAAACTGGCTTATCAAGCAGGTGATTTGGACAAGGCTCAATCATACGTGAAAAAAGCAGAAAGCATTAAAGCTGCTCCTGAAGTAAACATGAACTTAGGTTTGATCGCTCTGGCTAAGGGTG ACAAAGCTGCTGCTGAGTCATACTTAGGTAAAGCTGCCGGTGCTAAAGAACTGAACGAAACATTGGGTAACCTGTACGTAGCTCAGGGACAATACGAAAGAGCAGTAAACGCATTTGGAGACACTAAAACAAACAGTGCTGCTTTGGCACAGATCCTGGCTAAGGACTACAACAAAGCTAAAAACAC TTTGGCTGGTATCTCAACTCCGGATGCTTACACA 0.2% of data from the machine Put data in to big computer Push button on big computer 32

Results from big computer (P. goldsteinii) 33 WHAT???

Conclusion No single completely perfect method for carbapenemase characterization Use a mixture of methods if possible Whole genome sequencing is definitely an excellent confirmatory tool 34 Thank you for your attention! the second mentometerfråga 13-05-2015